Literature DB >> 8024016

Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation.

P Wang1, Z F Ba, I H Chaudry.   

Abstract

Although depressed endothelium-dependent relaxation occurs during early sepsis, the precise mechanism responsible for this remains unknown. Because the elevated levels of plasma tumor necrosis factor (TNF) play a major role in the pathophysiology of sepsis, we investigated whether TNF-alpha administration alters endothelium-dependent relaxation. To study this, recombinant TNF-alpha (1.2 x 10(7) U/mg) was infused intravenously (0.25 mg/kg body wt) for 0.5 h in normal rats, and mean arterial pressure was monitored. At 1 h after the completion of TNF-alpha or vehicle infusion, the aorta and a pulmonary artery were isolated, cut into 2.5-mm rings, and placed in organ chambers. Norepinephrine (2 x 10(-7) M) was applied to achieve near-maximal contraction, and dose responses for an endothelium-dependent vasodilator, acetylcholine, and an endothelium-independent vasodilator, nitroglycerine, were determined. In additional studies, aortic rings from normal animals were incubated with TNF-alpha for 2 h in vitro, and vascular reactivity was determined. The results indicate that TNF-alpha administration significantly reduced acetylcholine-induced vascular relaxation both in vivo and in vitro. Such a reduction was sustained at least 80 min after the completion of 2-h incubation with TNF-alpha. In contrast, TNF did not alter nitroglycerine-induced vascular relaxation. Thus TNF-alpha depresses endothelium-dependent relaxation in vitro as well as in vivo. Because TNF-alpha infusion increases plasma TNF levels without decreasing mean arterial pressure, the depressed endothelium-dependent relaxation observed during early sepsis may be due to the elevated circulating levels of TNF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024016     DOI: 10.1152/ajpheart.1994.266.6.H2535

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

Review 1.  Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.

Authors:  Tomohito Gohda; Yasuhiko Tomino
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 2.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

3.  Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia.

Authors:  Mark W Cunningham; Aswathi Jayaram; Evangeline Deer; Lorena M Amaral; Venkata Ramana Vaka; Tarek Ibrahim; Denise C Cornelius; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2020-07-10       Impact factor: 2.108

Review 4.  Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.

Authors:  A E Schussheim; V Fuster
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

5.  Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Authors:  Katja B Vallbracht-Israng; Andreas Morguet; Peter L Schwimmbeck
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

6.  Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.

Authors:  Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A Babcock; Hunter Berry; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

Review 7.  Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.

Authors:  Kazim Husain; Wilfredo Hernandez; Rais A Ansari; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

8.  TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.

Authors:  Silvia Bosello; Angelo Santoliquido; Angelo Zoli; Cristiana Di Campli; Roberto Flore; Paolo Tondi; GianFranco Ferraccioli
Journal:  Clin Rheumatol       Date:  2007-12-13       Impact factor: 2.980

Review 9.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase.

Authors:  Kian Peng Koh; Yinong Wang; Tai Yi; Stephen L Shiao; Marc I Lorber; William C Sessa; George Tellides; Jordan S Pober
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.